Multi-Centre Phase IV Trial to Investigate the Immunogenicity of a New Liquid Formulation of Recombinant Human Growth Hormone in Adults With Growth Hormone Deficiency
Journal of Endocrinological Investigation - Switzerland
doi 10.1007/s40618-017-0818-4
Full Text
Open PDFAbstract
Available in full text
Date
February 27, 2018
Authors
Publisher
Springer Science and Business Media LLC